Fierce Pharma Week Europe Launches in Basel for 2027, Targeting Cross-Functional Pharma Leadership
核心洞察
Questex (搜索) announces the inaugural Fierce Pharma Week Europe, scheduled for June 28–30, 2027, in Basel, Switzerland, a major European life sciences hub.
The event will feature dedicated content tracks across marketing, medical affairs, commercialization, PR, competitive intelligence, and market research for cross-functional pharma leaders.
Sessions will address critical issues including evolving U.S. drug-pricing policy, the European Commission's Life Sciences Strategy, and the rise of Chinese biopharma innovation.
Questex (搜索), the owner of Fierce Pharma and Fierce Pharma Week, has announced the launch of Fierce Pharma Week Europe, a new annual event dedicated to the business of pharma. The inaugural edition will take place June 28–30, 2027, in Basel, Switzerland, positioning the conference at the heart of Europe's most concentrated life sciences cluster.
The event will bring together leaders across marketing, medical affairs, commercialization and market access, PR and communications, competitive intelligence, and market research. By creating dedicated content tracks and community zones for each discipline, Fierce Pharma Week Europe aims to serve as a single gathering place for cross-functional teams driving the future of pharma.
"With the launch of Fierce Pharma Week Europe, we are creating a unique environment for cross-functional pharma teams to learn and network across companies and across countries. Europe is not one market, and our content programming will reflect that with sessions that cover the critical issues being addressed across this fragmented space," said Zohaib Sheikh, Head of Conference Programming, Fierce Life Sciences.
A Forum for a Rapidly Changing Landscape
European pharmaceutical companies are navigating a period of significant transformation. According to the announcement, key forces reshaping the market include an evolving U.S. drug-pricing policy, the European Commission's new Life Sciences Strategy, and the rapid rise of Chinese biopharma innovation. These developments are altering how global pharma companies approach the European market, fueling demand for a dedicated forum where such issues can be discussed.
The conference program will address a range of pressing topics, including the new geography of innovation and where Europe's next blockbuster drugs will originate, the geopolitics of drug pricing with sessions on U.S. MFN, AMNOG reforms, and JCA implementation, and launch excellence in a constrained, multi-market environment. Additional sessions will cover building omnichannel HCP engagement across Europe, deploying agentic AI at commercial scale within a regulated environment, the UK's post-Brexit pharma strategy amid the VPAG stalemate, and strategies for establishing digital and AI-forward commercial organizations.
Why Basel
Basel was selected as the host city for its unparalleled position in the European life sciences ecosystem. The city is home to global pharmaceutical leaders Novartis and Roche and sits at the center of a region boasting more than 800 life sciences companies, over 1,000 research groups, and more than 33,000 life sciences professionals. Located at the crossroads of Switzerland, Germany, and France, Basel offers convenient access via its international airport and one of Europe's best-connected rail hubs.
"Europe is entering a new era of pharmaceutical competition, and there has never been a better time to bring the Fierce Pharma Week franchise to the region," said Rhiannon James, President, Life Sciences, Health & Wellness at Questex (搜索). "Bringing Fierce Pharma Week to Basel puts that conversation right at the center of Europe's life sciences ecosystem, alongside the companies and policymakers who are living through these changes in pricing, market access, and global competition every day."
For the launch, Fierce Pharma is partnering with MCH Group (搜索) (Messe Schweiz), a Basel-based institution with deep experience connecting pharma, biotech, and life sciences stakeholders. Roman Imgrüth, CEO Exhibitions & Events at MCH Group, stated, "For many years, Fierce Pharma Week has been one of the pharmaceutical industry's flagship events in the United States. We are proud that Questex (搜索) has chosen Basel as the home of its European edition. With its globally recognised life sciences ecosystem, Basel is the ideal place to bring together leaders from across the industry."
Further details on programming, speakers, and sponsorship opportunities will be announced in the coming months. Organizations interested in early partnership opportunities are encouraged to contact the Fierce Pharma team directly.